Categories: HealthcareNews

Teladoc Health to Announce Third Quarter 2022 Financial Results

PURCHASE, NY, Oct. 11, 2022 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2022 results on Wednesday, October 26, 2022, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Conference Call Details
The conference call can be accessed by dialing 1-844-200-6205 for U.S. participants, or 1-929-526-1599 for international participants, and using the access code # 270257; or via a live audio webcast that will be available online at https://ir.teladochealth.com/news-and-events/events-and-presentations/.

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com or follow @TeladocHealth on Twitter.

Investors:
Patrick Feeley
914-265-7925
IR@teladochealth.com

 

Staff

Recent Posts

PLHM Expands Presence in Alberta with Acquisition of a Clinic in Fort Saskatchewan and an Additional Virtual Presence Across Canada

Calgary, Alberta--(Newsfile Corp. - April 4, 2024) - PLHM, a leading healthcare solutions provider, is…

1 hour ago

Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announces a…

2 hours ago

AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO): Fiscal Year 2024 Third Quarter Highlights Completed the sale…

2 hours ago

AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE

New Indication for Treatment of Pulmonary Embolism Enhances Device Utility in Critical Medical ScenariosLATHAM, N.Y.--(BUSINESS…

2 hours ago

Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events…

2 hours ago